Skip to main content
Top
Published in: Breast Cancer Research 1/2016

Open Access 01-12-2016 | Research article

Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry

Authors: Wanqing Wen, Xiao-ou Shu, Xingyi Guo, Qiuyin Cai, Jirong Long, Manjeet K. Bolla, Kyriaki Michailidou, Joe Dennis, Qin Wang, Yu-Tang Gao, Ying Zheng, Alison M. Dunning, Montserrat García-Closas, Paul Brennan, Shou-Tung Chen, Ji-Yeob Choi, Mikael Hartman, Hidemi Ito, Artitaya Lophatananon, Keitaro Matsuo, Hui Miao, Kenneth Muir, Suleeporn Sangrajrang, Chen-Yang Shen, Soo H. Teo, Chiu-chen Tseng, Anna H. Wu, Cheng Har Yip, Jacques Simard, Paul D. P. Pharoah, Per Hall, Daehee Kang, Yongbing Xiang, Douglas F. Easton, Wei Zheng

Published in: Breast Cancer Research | Issue 1/2016

Login to get access

Abstract

Background

Approximately 100 common breast cancer susceptibility alleles have been identified in genome-wide association studies (GWAS). The utility of these variants in breast cancer risk prediction models has not been evaluated adequately in women of Asian ancestry.

Methods

We evaluated 88 breast cancer risk variants that were identified previously by GWAS in 11,760 cases and 11,612 controls of Asian ancestry. SNPs confirmed to be associated with breast cancer risk in Asian women were used to construct a polygenic risk score (PRS). The relative and absolute risks of breast cancer by the PRS percentiles were estimated based on the PRS distribution, and were used to stratify women into different levels of breast cancer risk.

Results

We confirmed significant associations with breast cancer risk for SNPs in 44 of the 78 previously reported loci at P < 0.05. Compared with women in the middle quintile of the PRS, women in the top 1% group had a 2.70-fold elevated risk of breast cancer (95% CI: 2.15–3.40). The risk prediction model with the PRS had an area under the receiver operating characteristic curve of 0.606. The lifetime risk of breast cancer for Shanghai Chinese women in the lowest and highest 1% of the PRS was 1.35% and 10.06%, respectively.

Conclusion

Approximately one-half of GWAS-identified breast cancer risk variants can be directly replicated in East Asian women. Collectively, common genetic variants are important predictors for breast cancer risk. Using common genetic variants for breast cancer could help identify women at high risk of breast cancer.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ghoussaini M, Pharoah PD, Easton DF. Inherited genetic susceptibility to breast cancer: the beginning of the end or the end of the beginning? Am J Pathol. 2013;183(1525–2191 (Electronic)):1038–51.CrossRefPubMed Ghoussaini M, Pharoah PD, Easton DF. Inherited genetic susceptibility to breast cancer: the beginning of the end or the end of the beginning? Am J Pathol. 2013;183(1525–2191 (Electronic)):1038–51.CrossRefPubMed
2.
go back to reference Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson SA, et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet. 2007;39(7):865–9.CrossRefPubMed Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson SA, et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet. 2007;39(7):865–9.CrossRefPubMed
3.
go back to reference Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, Cox DG, et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet. 2009;41(5):579–84.CrossRefPubMedPubMedCentral Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, Cox DG, et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet. 2009;41(5):579–84.CrossRefPubMedPubMedCentral
4.
go back to reference Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet. 2010;42(6):504–7.CrossRefPubMedPubMedCentral Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet. 2010;42(6):504–7.CrossRefPubMedPubMedCentral
5.
go back to reference Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet. 2013;45(1546–1718 (Electronic)):353–61.CrossRefPubMedPubMedCentral Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet. 2013;45(1546–1718 (Electronic)):353–61.CrossRefPubMedPubMedCentral
6.
go back to reference Michailidou K, Beesley J, Lindstrom S, Canisius S, Dennis J, Lush MJ, et al. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nat Genet. 2015;47(4):373–80.CrossRefPubMedPubMedCentral Michailidou K, Beesley J, Lindstrom S, Canisius S, Dennis J, Lush MJ, et al. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nat Genet. 2015;47(4):373–80.CrossRefPubMedPubMedCentral
7.
go back to reference Zheng W, Long J, Gao YT, Li C, Zheng Y, Xiang YB, et al. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet. 2009;41(1546–1718 (Electronic)):324–8.CrossRefPubMedPubMedCentral Zheng W, Long J, Gao YT, Li C, Zheng Y, Xiang YB, et al. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet. 2009;41(1546–1718 (Electronic)):324–8.CrossRefPubMedPubMedCentral
8.
go back to reference Long J, Cai Q, Shu XO, Qu S, Li C, Zheng Y, et al. Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium. PLoS Genet. 2010;6(1553–7404 (Electronic)):e1001002.CrossRefPubMedPubMedCentral Long J, Cai Q, Shu XO, Qu S, Li C, Zheng Y, et al. Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium. PLoS Genet. 2010;6(1553–7404 (Electronic)):e1001002.CrossRefPubMedPubMedCentral
9.
go back to reference Cai Q, Long J, Lu W, Qu S, Wen W, Kang D, et al. Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium. Hum Mol Genet. 2011;20(1460–2083 (Electronic)):4991–9.CrossRefPubMedPubMedCentral Cai Q, Long J, Lu W, Qu S, Wen W, Kang D, et al. Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium. Hum Mol Genet. 2011;20(1460–2083 (Electronic)):4991–9.CrossRefPubMedPubMedCentral
10.
go back to reference Long J, Cai Q, Sung H, Shi J, Zhang B, Choi JY, et al. Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer. PLoS Genet. 2012;8(1553–7404 (Electronic)):e1002532.CrossRefPubMedPubMedCentral Long J, Cai Q, Sung H, Shi J, Zhang B, Choi JY, et al. Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer. PLoS Genet. 2012;8(1553–7404 (Electronic)):e1002532.CrossRefPubMedPubMedCentral
11.
go back to reference Cai Q, Zhang B, Sung H, Low SK, Kweon SS, Lu W, et al. Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1. Nat Genet. 2014;46(1546–1718 (Electronic)):886–90.CrossRefPubMedPubMedCentral Cai Q, Zhang B, Sung H, Low SK, Kweon SS, Lu W, et al. Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1. Nat Genet. 2014;46(1546–1718 (Electronic)):886–90.CrossRefPubMedPubMedCentral
12.
go back to reference Long J, Delahanty RJ, Li G, Gao YT, Lu W, Cai Q, et al. A common deletion in the APOBEC3 genes and breast cancer risk. J Natl Cancer Inst. 2013;105(8):573–9.CrossRefPubMedPubMedCentral Long J, Delahanty RJ, Li G, Gao YT, Lu W, Cai Q, et al. A common deletion in the APOBEC3 genes and breast cancer risk. J Natl Cancer Inst. 2013;105(8):573–9.CrossRefPubMedPubMedCentral
13.
go back to reference Zheng W, Zhang B, Cai Q, Sung H, Michailidou K, Shi J, et al. Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls. Hum Mol Genet. 2013;22(1460–2083 (Electronic)):2539–50.CrossRefPubMedPubMedCentral Zheng W, Zhang B, Cai Q, Sung H, Michailidou K, Shi J, et al. Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls. Hum Mol Genet. 2013;22(1460–2083 (Electronic)):2539–50.CrossRefPubMedPubMedCentral
14.
go back to reference Lee CP, Irwanto A, Salim A, Yuan JM, Liu J, Koh WP, et al. Breast cancer risk assessment using genetic variants and risk factors in a Singapore Chinese population. Breast Cancer Res. 2014;16(1465-542X (Electronic)):R64.CrossRefPubMedPubMedCentral Lee CP, Irwanto A, Salim A, Yuan JM, Liu J, Koh WP, et al. Breast cancer risk assessment using genetic variants and risk factors in a Singapore Chinese population. Breast Cancer Res. 2014;16(1465-542X (Electronic)):R64.CrossRefPubMedPubMedCentral
15.
go back to reference Mavaddat N, Pharoah P, Michailidou K. Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst. 2015;107(5):djv036.CrossRefPubMedPubMedCentral Mavaddat N, Pharoah P, Michailidou K. Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst. 2015;107(5):djv036.CrossRefPubMedPubMedCentral
16.
go back to reference Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet. 2002;31(1061–4036 (Print)):33–6.CrossRefPubMed Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet. 2002;31(1061–4036 (Print)):33–6.CrossRefPubMed
17.
go back to reference Pfeiffer RM, Gail MH. Two criteria for evaluating risk prediction models. Biometrics. 2011;67(3):1057–65.CrossRefPubMed Pfeiffer RM, Gail MH. Two criteria for evaluating risk prediction models. Biometrics. 2011;67(3):1057–65.CrossRefPubMed
19.
go back to reference DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–45.CrossRefPubMed DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–45.CrossRefPubMed
20.
go back to reference Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(0027–8874 (Print)):1879–86.CrossRefPubMed Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(0027–8874 (Print)):1879–86.CrossRefPubMed
21.
go back to reference Zheng W, Wen W, Gao YT, Shyr Y, Zheng Y, Long J, et al. Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women. J Natl Cancer Inst. 2010;102(1460–2105 (Electronic)):972–81.CrossRefPubMedPubMedCentral Zheng W, Wen W, Gao YT, Shyr Y, Zheng Y, Long J, et al. Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women. J Natl Cancer Inst. 2010;102(1460–2105 (Electronic)):972–81.CrossRefPubMedPubMedCentral
22.
24.
go back to reference Locatelli I, Lichtenstein P, Yashin AI. The heritability of breast cancer: a Bayesian correlated frailty model applied to Swedish twins data. Twin Res Off J Int Soc Twin Stud. 2004;7(2):182–91.CrossRef Locatelli I, Lichtenstein P, Yashin AI. The heritability of breast cancer: a Bayesian correlated frailty model applied to Swedish twins data. Twin Res Off J Int Soc Twin Stud. 2004;7(2):182–91.CrossRef
25.
go back to reference Husing A, Canzian F, Beckmann L, Garcia-Closas M, Diver WR, Thun MJ, et al. Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status. J Med Genet. 2012;49(1468–6244 (Electronic)):601–8.CrossRefPubMedPubMedCentral Husing A, Canzian F, Beckmann L, Garcia-Closas M, Diver WR, Thun MJ, et al. Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status. J Med Genet. 2012;49(1468–6244 (Electronic)):601–8.CrossRefPubMedPubMedCentral
Metadata
Title
Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry
Authors
Wanqing Wen
Xiao-ou Shu
Xingyi Guo
Qiuyin Cai
Jirong Long
Manjeet K. Bolla
Kyriaki Michailidou
Joe Dennis
Qin Wang
Yu-Tang Gao
Ying Zheng
Alison M. Dunning
Montserrat García-Closas
Paul Brennan
Shou-Tung Chen
Ji-Yeob Choi
Mikael Hartman
Hidemi Ito
Artitaya Lophatananon
Keitaro Matsuo
Hui Miao
Kenneth Muir
Suleeporn Sangrajrang
Chen-Yang Shen
Soo H. Teo
Chiu-chen Tseng
Anna H. Wu
Cheng Har Yip
Jacques Simard
Paul D. P. Pharoah
Per Hall
Daehee Kang
Yongbing Xiang
Douglas F. Easton
Wei Zheng
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 1/2016
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/s13058-016-0786-1

Other articles of this Issue 1/2016

Breast Cancer Research 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine